Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07217756

Impact of Increased Body Mass Index on Adolescent Fixed Orthodontic Treatment. A Prospective Longitudinal Study

The goal of this prospective observational study is to assess the influence of increased body mass index (BMI) on various oral health and orthodontic-related parameters in adolescents undergoing orthodontic therapy (OT) with braces. These parameters include gum inflammation, tooth decalcifications/discolorations, tooth alignment of lower incisors, and various inflammatory and microbiological parameters in the collected saliva and gum fluid of the patients. The primary purpose is to assess if an increased BMI is a risk factor for oral inflammation in adolescents undergoing OT. The main questions it aims to answer are:

1. Do patients with an increased BMI undergoing OT demonstrate increased microbial counts in the saliva compared to patients with normal BMI? 2. Do patients with increased BMI undergoing OT demonstrate increased gum inflammation, tooth discolorations, and higher levels of inflammatory markers in the saliva and gum fluid samples compared to patients with normal BMI? This study will include 2 study groups (patients with increased BMI-test group, and normal weight patients-control group). The participants will be asked to complete a study questionnaire, which will collect information regarding their demographics, their family socioeconomic and educational status, dietary habits, and oral health-related quality of life. The participants will also receive an oral examination (evaluation of their gum health), and they will have their intraoral photos taken, as well as an impression of their lower teeth (to create dental models). A saliva sample will be obtained by asking patients to passively "drool" in a tube, and a gingival fluid sample will be collected from the gums of the lower anterior teeth using thin paper strips. All these study procedures will be conducted at baseline (T1: before bonding of braces), and at an approximately 6-month follow-up visit (T2). Comparisons of these outcomes will be conducted between the two groups and across timepoints.

Recruiting

Interested in participating?

Request Info

Key information

Age range

12 year–18 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Eastman Institute for Oral Health, University of Rochester

Rochester, New York, 14620, United States

Location status: Recruiting

Location contact

Atoosa Pahlavani, DDS, MS

SUB_INVESTIGATOR

Dimitrios Michelogiannakis, DDS, MS

CONTACT

[email protected]

585-275-5012

Dimitrios Michelogiannakis, DDS, MS

PRINCIPAL_INVESTIGATOR

Elli Anna Kotsailidi, DDS, MS

SUB_INVESTIGATOR

Ibrahim Kassem, DDS, MS

SUB_INVESTIGATOR

Jin Xiao, DDS, PhD

SUB_INVESTIGATOR

Luis Mendez, DDS

SUB_INVESTIGATOR

Paul Emile Rossouw, DDS, PhD

SUB_INVESTIGATOR

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • adolescents (12-17 years old);
  • patients scheduled to undergo comprehensive fixed orthodontic therapy (OT) (for at least 6 months with metal braces/wires) on both dental arches;
  • patients with increased BMI (≥25.0 Kg/m2) (test-Group);
  • patients with normal BMI [18.5-24.99 (Kg/m2)] (control-Group);
  • patients with all 6 mandibular anterior teeth present and mild-to-moderate mandibular crowding (<7.5 mm);
  • patients and parents/guardians willing to provide signed assent/permission.

Exclusion criteria

  • self-reported habitual tobacco product users;
  • patients with self-reported medical diseases such as hepatic diseases, blood disorders, cardiovascular diseases, HIV, diabetes mellitus, and viral infections;
  • patients with craniofacial syndromes and/or cleft lip and palate;
  • pregnant and/or lactating females (by self/parent report);
  • edentulous individuals;
  • patients with active or a history of periodontitis;
  • patients having undergone surgical and/or non-surgical periodontal therapy within the past 6 months;
  • patients with physical and/or mental/cognitive disabilities who are decisionally-impaired and not able to consent/assent for themselves;
  • patients who reported use of medications such as antibiotics, steroids (inhalers and/or pills), non-steroidal anti-inflammatory drugs, and antimicrobial mouth-rinses within the past 3 months or those who require prophylactic antibiotics prior to dental procedures;
  • patients undergoing cancer therapy;
  • underweight patients (BMI less than 18.5 Kg/m2);
  • patients with oral mucosal lesions such as median rhomboid glossitis and lichen planus;
  • patients with clinically visible carious teeth.

Treatment and study plan

Primary outcomes

  1. Mean Change in Full-Mouth Bleeding Score (FMBS)

    Time frame: Baseline (T1: before bonding of braces) and approximately 6 months follow-up (T2)

    Bleeding on probing (BOP) will be assessed dichotomously (yes/no) at six sites per tooth (mesio-buccal, mid-buccal, disto-buccal, mesio-lingual/palatal, mid-lingual/palatal, and disto-lingual/palatal) using a standardized periodontal probe by trained examiners. The full-mouth bleeding score (FMBS) will be calculated as the percentage of sites that bleed out of the total number of sites examined. Higher percentages indicate greater gingival inflammation.

  2. Mean Change in White Spot Lesion (WSL) Score (International Caries Detection and Assessment System (ICDAS))

    Time frame: Baseline (T1: before bonding of braces) and approximately 6 months follow-up (T2)

    Standardized intraoral and facial photographs will be taken using calibrated camera settings and stored in Dolphin Imaging Software. Each visible tooth surface will be examined for color, texture, and cavitation changes and scored using the International Caries Detection and Assessment System (ICDAS). Code 0 = sound surface; code 2 = visible white spot lesion; codes 3-4 = localized enamel breakdown or dentin shadowing; codes 5-6 = cavitated lesions extending into dentin. Because photos are obtained without air drying, code 1 will be excluded. The average WSL score per participant will be calculated by dividing the total ICDAS score by the number of surfaces assessed. Mean change = score at T2 minus score at T1. Higher scores indicate greater enamel decalcification.

  3. Mean Change in Salivary Microbial Counts of Candida albicans and Streptococcus mutans

    Time frame: Baseline (T1: before bonding of braces) and approximately 6 months follow-up (T2)

    Unstimulated whole saliva will be collected at baseline and follow-up. C. albicans will be cultured on CHROMagar™ Candida and confirmed via germ tube test from three colonies per sample. S. mutans will be cultured on Mitis Salivarius Bacitracin medium and identified by colony morphology. DNA-based microbial identification and oral microbiome sequencing with bioinformatics analysis will also be performed. Microbial counts will be reported per participant as colony-forming units per milliliter (CFU/mL) or relative abundance. Higher values indicate greater microbial load.

Secondary outcomes

  1. Mean Change in Body Mass Index (BMI)

    Time frame: Baseline (T1) and approximately 6 months follow-up (T2)

    Height (cm) will be measured using a stadiometer, and weight (kg) with a calibrated digital scale. BMI will be calculated as weight (kg)/height² (m²). Measurements will be taken twice and averaged. Higher BMI indicates greater body mass relative to height.

  2. Mean Change in Full-Mouth Plaque Score (FMPS)

    Time frame: Baseline (T1) and approximately 6 months follow-up (T2)

    Plaque presence will be recorded on four surfaces per tooth (mesial, distal, buccal, lingual/palatal). The FMPS will be calculated as the percentage of surfaces with plaque present out of total surfaces examined. Higher percentages indicate poorer oral hygiene.

  3. Mean Change in Percentage of Sites with Probing Depth >3 mm

    Time frame: Baseline (T1) and approximately 6 months follow-up (T2)

    Probing depth (PD) will be measured at six sites per tooth using a periodontal probe. The percentage of sites with PD greater than 3 mm will be calculated for each participant. Higher percentages indicate more severe periodontal disease.

  4. Mean Change in Oral Dryness Score (Challacombe Scale)

    Time frame: Baseline (T1) and approximately 6 months follow-up (T2)

    Oral dryness will be assessed using the Challacombe Scale, which rates 10 indicators of xerostomia (e.g., lack of saliva pooling, frothy saliva, depapillation, fissured tongue). Scores range from 1 to 10, with 1-3 indicating mild dryness, 4-6 moderate, and 7-10 severe. Higher scores indicate greater dryness.

  5. Mean Change in Little's Irregularity Index (Tooth Alignment)

    Time frame: Baseline (T1) and approximately 6 months follow-up (T2)

    Dental casts made from alginate impressions will be analyzed using a digital caliper (accuracy 0.01 mm). The sum of the linear displacements between the anatomic contact points of the mandibular incisors (five measurements) yields Little's Irregularity Index. Higher values indicate greater misalignment.

  6. Mean Change in Salivary Proinflammatory Biomarker Concentrations (IL-1β, IL-6, TNF-α, Leptin, Resistin)

    Time frame: Baseline (T1) and approximately 6 months follow-up (T2)

    Salivary and gingival crevicular fluid samples will be centrifuged and analyzed using multiplexed magnetic bead assays (Milliplex MAP). Concentrations will be calculated from standard curves. Higher levels indicate greater inflammatory activity.

  7. Mean Change in Dietary Habits Score

    Time frame: Baseline (T1) and approximately 6 months follow-up (T2)

    Participants will complete a standardized questionnaire assessing dietary habits related to oral health and obesity. Responses will be scored to produce a composite dietary habits score; higher scores indicate less healthy dietary patterns.

  8. Mean Change in Oral Health-Related Quality of Life (OHIP-14 Total Score)

    Time frame: Baseline (T1) and approximately 6 months follow-up (T2)

    The Oral Health Impact Profile-14 (OHIP-14) questionnaire will assess functional limitation, pain, and psychological and social impacts of oral health. Scores from 14 items are summed (range 0-56); higher scores indicate poorer oral health-related quality of life.

Study contacts

Contact information is provided by the study sponsor or research team.

Dimitrios Michelogiannakis, DDS, MS

CONTACT

[email protected]

585-275-5012

Sponsors and collaborators

Lead sponsor

University of Rochester

Other

Collaborators

  • American Association of Orthodontists Foundation

Registry information

Official study title

Influence of Body Mass Index on Gingival Health, White Spot Lesions, Whole Salivary Proinflammatory Cytokine and Adipokine Profile and Candida and Streptococcus Mutans Carriage Among Adolescents Undergoing Fixed Orthodontic Therapy

Important dates

Study start
2022
Primary completion
2026
Study completion
2026
First posted
Oct 16, 2025
Registry last updated
Oct 20, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.